Patents by Inventor Timothy Michael Ramsey

Timothy Michael Ramsey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating ocular disease using inhibitors of CSF-1R
    Patent number: 10537563
    Abstract: The present invention provides in one aspect methods for treating ocular diseases by administering pharmaceutical compositions comprising an inhibitor of colony stimulating factor-1 (CSF-1) receptors. In another aspect, the present invention provides pharmaceutical compositions for treating ocular diseases, the compositions comprising at least one inhibitor of CSF-1R. The inhibitor can also be a selective inhibitor of CSF-1R in certain embodiments.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: January 21, 2020
    Assignee: NOVARTIS AG
    Inventors: Christopher Adams, Muneto Mogi, Stephen Hedrick Poor, Timothy Michael Ramsey, Henry Wu, Qin Zhang
  • METHODS FOR TREATING OCULAR DISEASE USING INHIBITORS OF CSF-1R
    Publication number: 20190231765
    Abstract: The present invention provides in one aspect methods for treating ocular diseases by administering pharmaceutical compositions comprising an inhibitor of colony stimulating factor-1 (CSF-1) receptors. In another aspect, the present invention provides pharmaceutical compositions for treating ocular diseases, the compositions comprising at least one inhibitor of CSF-1R. The inhibitor can also be a selective inhibitor of CSF-1R in certain embodiments.
    Type: Application
    Filed: October 13, 2017
    Publication date: August 1, 2019
    Inventors: Christopher ADAMS, Muneto MOGI, Stephen Hedrick POOR, Timothy Michael RAMSEY, Henry WU, Qin ZHANG
  • Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives
    Patent number: 7691855
    Abstract: The invention relates to phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives—alone or in combination with one or more other pharmaceutically active compounds—for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumor.
    Type: Grant
    Filed: July 8, 2003
    Date of Patent: April 6, 2010
    Assignee: Novartis AG
    Inventors: Pascal Furet, Patricia Imbach, Timothy Michael Ramsey, Achim Schlapbach, Dieter Scholz, Giorgio Caravatti
  • Organic Compounds
    Publication number: 20090069360
    Abstract: The present invention relates to the discovery that certain compounds inhibit, regulate and/or modulate tyrosine and serine/threonine kinase and kinase-like proteins, such as RAF kinase, a serine/threonine kinase that functions in the MAP kinase signaling pathway, and is concerned with compositions which contain these compounds, and methods of using them to treat tyrosine and serine/threonine kinase and kinase-like dependent diseases, such as angiogenesis, cancer and cardiac hypertrophy.
    Type: Application
    Filed: March 14, 2007
    Publication date: March 12, 2009
    Inventors: David Bryant Batt, Rene Beerli, Guido Bold, Giorgio Caravatti, Timothy Michael Ramsey
  • Inhibitors of the E2F-1/cyclin interaction for cancer therapy
    Publication number: 20040077549
    Abstract: The novel compounds of this invention have the general structural formula Ia-d: The compounds of this invention relate to 8-mer, 7-mer, 6-mer and 5-mer peptides having the following amino acid-sequences, and referred to collectively as having “Formula Ia-d”: 1 Cap-AA8-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 8-mer la Cap-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 7-mer lb Cap-AA6-AA5-AA4*-AA3-AA2-AA1* 6-mer lc Cap-AA5-AA4*-AA3-AA2-AA1* 5-mer ld
    Type: Application
    Filed: June 27, 2003
    Publication date: April 22, 2004
    Inventors: Kenneth Walter Bair, YingNan Pan Chen, Timothy Michael Ramsey, Michael Lloyd Sabio, Sushil Kumar Sharma
  • Inhibitors of the E2F-1/cyclin interaction for cancer therapy
    Publication number: 20040053849
    Abstract: The novel compounds of this invention have the general structural formula Ia-d: The compounds of this invention relate to 8-mer, 7-mer, 6-mer and 5-mer peptides having the following amino acid sequences, and referred to collectively as having “Formula Ia-d”: 1 Cap-AA8-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 8-mer Ia Cap-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 7-mer Ib Cap-AA6-AA5-AA4*-AA3-AA2-AA1* 6-mer Ic Cap-AA5-AA4*-AA3-AA2-AA1* 5-mer Id
    Type: Application
    Filed: June 25, 2003
    Publication date: March 18, 2004
    Inventors: Kenneth Walter Bair, YingNan Pan Chen, Timothy Michael Ramsey, Michael Lloyd Sabio, Sushil Kumar Sharma
  • Inhibitors of the E2F-1/cyclin interaction for cancer therapy
    Publication number: 20020142966
    Abstract: The novel compounds of this invention have the general structural formula Ia-d: The compounds of this invention relate to 8-mer, 7-mer, 6-mer and 5-mer peptides having the following amino acid sequences, and referred to collectively as having “Formula Ia-d”: 1 Cap-AA8-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 8-mer Ia Cap-AA7-AA6-AA5-AA4*-AA3-AA2-AA1* 7-mer Ib Cap-AA6-AA5-AA4*-AA3-AA2-AA1* 6-mer Ic Cap-AA5-AA4*-AA3-AA2-AA1* 5-mer Id
    Type: Application
    Filed: December 19, 2001
    Publication date: October 3, 2002
    Inventors: Kenneth Walter Bair, YingNan Pan Chen, Timothy Michael Ramsey, Michael Lloyd Sabio, Sushil Kumar Sharma